By Liz Segrist
Published July 8, 2014
The Quebec-based biopharmaceutical company will occupy the third floor of the 100,000-square-foot SCRA Applied Technologies Center.
SCRA bought 10 acres in the 4,500-acre mixed-use community in spring 2013 with plans to relocate from North Charleston, to accommodate the expansion of the Boeing 787 Dreamliner campus along International Boulevard.
The new Applied Technologies Center will house SCRA’s Charleston-area operations and the majority of its local employees. Tenant companies will lease space as it is available.
Aeterna Zentaris, which develops treatments in oncology and endocrinology, is scheduled to move in upon completion this fall.
“SCRA is pleased to welcome Aeterna Zentaris to South Carolina,” SCRA CEO Bill Mahoney said in a statement. “This outstanding company is developing life-changing technologies and will be a significant cog in South Carolina’s knowledge economy.”
The Canadian company announced plans in May to start a commercial operation in the Charleston region. It moved into the SCRA Applied Research Center on International Boulevard in North Charleston for the short term with plans to relocate to Nexton.
Aeterna Zentaris plans to invest $1 million and create 60 jobs over the next few years, according to the S.C. Department of Commerce.
Aeterna Chairman and CEO David Dodd said he expects to expand the company’s staff for commercial operations, business development, regulatory and quality assurance, manufacturing management, clinical and product development and various administrative functions.
Aeterna plans to establish strategic partnerships with the Medical University of South Carolina and other clinical and research facilities in the area as part of its research and development.
Reach staff writer Liz Segrist at 843-849-3119 or @lizsegrist on Twitter.